ANI Pharmaceuticals, Inc. (ANIP) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for ANI Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 20.21x | -57.66x | 52.86x | -13.66x | -13.62x | -15.41x |
| P/B Ratio | 2.93x | 2.49x | 2.17x | 1.93x | 1.62x | 1.78x |
| P/S Ratio | 1.79x | 1.74x | 2.04x | 2.07x | 2.69x | 1.67x |
| Profitability | ||||||
| Gross Margin | 51.0% | 59.3% | 62.7% | 56.1% | 53.5% | 58.2% |
| Operating Margin | 9.2% | 0.1% | 9.6% | -11.2% | -18.4% | -7.7% |
| Net Margin | 8.9% | -3.0% | 3.9% | -15.1% | -19.7% | -10.8% |
| EBITDA Margin | 23.5% | 10.3% | 21.9% | 7.9% | 1.4% | 13.5% |
| Liquidity | ||||||
| Current Ratio | 2.71x | 2.72x | 3.57x | 3.46x | 3.68x | 2.17x |
| Quick Ratio | 2.19x | 2.02x | 2.81x | 2.40x | 2.74x | 1.39x |
| Leverage | ||||||
| Debt/Equity | 0.60x | 1.46x | 0.62x | 0.85x | 0.80x | 0.95x |
YoY = year-over-year change. Source: FMP..